US regulator orders blindness risk warning on obesity drugs
Food and Drug Administration cites increased risk of rare eye condition that can cause permanent vision loss in users of GLP-1s
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Financial Times World; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersTons of chilled and frozen food was spoiled last month as fridges and freezers in hundreds of supermarkets heated up.

Why it mattersThe effort will likely fail, but Representative Thomas Massie wants to push Trump to fire Hegseth before Democrats can launch their own impeachment process.

Why it mattersThe share price dropped wiped hundreds of billions of dollars from the value of Nvidia.

Why it mattersTrump made the claims, without evidence, on Truth Social on Monday.